Insight Molecular Diagnostics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMDX and other ETFs, options, and stocks.About IMDX
Insight Molecular Diagnostics, Inc. is a diagnostics technology company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO.
IMDX Key Statistics
Stock Snapshot
The current Insight Molecular Diagnostics(IMDX) stock price is $4.58, with a market capitalization of 147.97M. The stock trades at a price-to-earnings (P/E) ratio of -2.83.
During the trading session on 2026-05-06, Insight Molecular Diagnostics(IMDX) shares reached a daily high of $5.50 and a low of $4.39. At a current price of $4.58, the stock is +4.3% higher than the low and still -16.7% under the high.
Trading activity shows a volume of 851.32K, compared to an average daily volume of 537.59K.
The stock's 52-week range extends from a low of $2.33 to a high of $8.51.
The stock's 52-week range extends from a low of $2.33 to a high of $8.51.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.